ALS Stem Cell Trial Yielding “Impressively Positive” Findings
Commenting on the Phase IIa trial of NurOwn™–BrainStorm Cell Therapeutics’ stem cell therapy for amyotrophic lateral sclerosis (ALS)–which is being conducted at the Hadassah Medical Center, Prof. Dimitrios Karussis, principal…